Newsroom

Our central location for research news and other stories of related information can be found here.

Wednesday, November 9, 2011

The Christ Hospital is First in U.S. to Implant and is the Highest Enrolling Site for Investigational Second Generation MR-Conditional Pacemaker through Clinical Trial at Lindner Research Center

Edward J. Schloss, M.D., medical director of electrophysiology at The Christ Hospital, was the first in the U.S. to implant the Advisa MRI SureScan® Pacing System, Medtronic’s second-generation pacemaker system, as part of a clinical trial offered through The Carl and Edyth Lindner Center for Research and Education. The study is investigating whether this new system, designed to be compatible with magnetic resonance imaging (MRI) scanners, is safe and effective for use in the MRI environment on any body region.

Read the full story (PDF)

The Christ Hospital First in Ohio to Treat Patient with Drug-Coated Balloon

Physicians at The Carl and Edyth Lindner Center for Research and Education at The Christ Hospital (Lindner Research Center) have treated the first patient in the state of Ohio with the Moxy™ Drug Coated Balloon as part of LEVANT 2, a global, multi-center, randomized clinical trial evaluating the safety and efficacy of this device for the treatment of peripheral arterial disease (PAD). Monica Hunter, M.D., interventional cardiologist at The Christ Hospital and principal investigator at the Lindner Research Center, performed the case. The patient is doing well and has been discharged home.

Read the full story (PDF)

Tuesday, November 8, 2011

Boston Scientific Platinum Chromium ION™ Stent Demonstrates Positive Outcomes in PERSEUS Clinical Program

Boston Scientific Corporation (NYSE: BSX) reports positive long-term data from the PERSEUS clinical program, which demonstrated favorable two-year safety and effectiveness outcomes for the ION™ (TAXUS Element) Paclitaxel-Eluting Platinum Chromium Stent System versus prior-generation paclitaxel-eluting stents. Results were presented today by PERSEUS clinical program Principal Investigators Louis Cannon, M.D., of the Cardiac and Vascular Research Center of Northern Michigan in Petoskey, Michigan, and Dean Kereiakes, M.D., Medical Director at The Christ Hospital Heart and Vascular Center and The Lindner Research Center in Cincinnati, at the Cardiovascular Research Foundation's annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in San Francisco.

Read the full story